Fig. 2From: A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study5-year overall survival rates of retrospectively analysed postoperative patients without adjuvant chemotherapy. a Stage IA NSCLC with or without LVI. b 2 cm or less size Stage IA NSCLC with or without LVI. LVI, lymphovascular invasion; NSCLC, non-small cell carcinomaBack to article page